Polygenic Prediction of Substance Use Disorders in Clinical and Population Samples PB Barr et al, BioRXIV, August 2019

Main|Search|PHGKB




Last Posted: Sep 01, 2019

---

• Polygenic Prediction of Substance Use Disorders in Clinical and Population Samples
  PB Barr et al, BioRXIV, August 2019
• Association of a Primary Open-Angle Glaucoma Genetic Risk Score With Earlier Age at Diagnosis.
  Fan Bao Jian et al. JAMA ophthalmology 2019 Aug
• Polygenic Risk Scores: From Discovery to Implementation
  NHLBI May 23-24, 2019 Workshop Summary
• Assessment of Polygenic Architecture and Risk Prediction based on Common Variants Across Fourteen Cancers
  Y Zhan et al, BioRXIV preprint, August 9, 2019
• Evaluation of phenotyping errors on polygenic risk score predictions
  R Li et al, BioRXIV preprints, August 4, 2019
• Low coverage whole genome sequencing enables accurate assessment of common variants and calculation of genome-wide polygenic scores
  JR Homburger et al, BioxRIV preprints, July 31, 2019
• Towards clinical utility of polygenic risk scores 
  SA Lambert et al, Hum Mol Genetics, July 31, 2019
• A Weighted Genetic Risk Score Based on Four APOE-Independent Alzheimer's Disease Risk Loci May Supplement APOE E4 for Better Disease Prediction.
  Zhang Chunyu et al. Journal of molecular neuroscience : MN 2019 Jul
• Genetic risk scores for diabetes diagnosis and precision medicine.
  Udler Miriam S et al. Endocrine reviews 2019 Jul
• Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects.
  Gill Dipender et al. Circulation 2019 Jul 140(4) 270-279

more